[1483] | 1 | <?xml version="1.0" encoding="UTF-8"?>
|
---|
| 2 | <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
|
---|
| 3 | <rdf:Description rdf:about="/dewdrop/patient/32/allergy/1">
|
---|
| 4 | <adverseEventType_value>D</adverseEventType_value>
|
---|
| 5 | <comments-comment_commentText>active </comments-comment_commentText>
|
---|
| 6 | <comments-comment_commentType>O</comments-comment_commentType>
|
---|
| 7 | <comments-comment_enteredBy>KING,MATTHEW MICHAEL</comments-comment_enteredBy>
|
---|
| 8 | <comments-comment_entered>3110624.190941</comments-comment_entered>
|
---|
| 9 | <comments-comment_id>1</comments-comment_id>
|
---|
| 10 | <drugIngredients-drugIngredient_name>PENICILLIN</drugIngredients-drugIngredient_name>
|
---|
| 11 | <drugIngredients-drugIngredient_vuid>4019880</drugIngredients-drugIngredient_vuid>
|
---|
| 12 | <entered_value>3110624.1909</entered_value>
|
---|
| 13 | <facility_code>050</facility_code>
|
---|
| 14 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 15 | <id_value>57</id_value>
|
---|
| 16 | <localCode_value>2505;PS(50.416,</localCode_value>
|
---|
| 17 | <mechanism_value>ALLERGY</mechanism_value>
|
---|
| 18 | <name_value>PENICILLIN</name_value>
|
---|
| 19 | <rdf:type rdf:resource="allergy"/>
|
---|
| 20 | <reactions-reaction_name>HIVES</reactions-reaction_name>
|
---|
| 21 | <severity_value>MODERATE</severity_value>
|
---|
| 22 | <source_value>O</source_value>
|
---|
| 23 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 24 | <vuid_value>4019880</vuid_value>
|
---|
| 25 | </rdf:Description>
|
---|
| 26 | <rdf:Description rdf:about="/dewdrop/patient/32/lab/1">
|
---|
| 27 | <collected_value>3110626.16</collected_value>
|
---|
| 28 | <space xmlns="comment@xml">preserve</space>
|
---|
| 29 | <comment>Report Released Date/Time: Jun 26, 2011@19:00</comment>
|
---|
| 30 | <facility_code>100</facility_code>
|
---|
| 31 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 32 | <groupName_value>CH 0626 47</groupName_value>
|
---|
| 33 | <high_value> 26</high_value>
|
---|
| 34 | <id_value>CH;6889372.84;3</id_value>
|
---|
| 35 | <labOrderID_value>336</labOrderID_value>
|
---|
| 36 | <localName_value>BUN</localName_value>
|
---|
| 37 | <loinc_value>14937-7</loinc_value>
|
---|
| 38 | <low_value>6 </low_value>
|
---|
| 39 | <orderID_value>809</orderID_value>
|
---|
| 40 | <rdf:type rdf:resource="lab"/>
|
---|
| 41 | <result_value>18</result_value>
|
---|
| 42 | <resulted_value>3110626.190006</resulted_value>
|
---|
| 43 | <sample_value>SERUM</sample_value>
|
---|
| 44 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 45 | <specimen_code>0X500</specimen_code>
|
---|
| 46 | <specimen_name>SERUM</specimen_name>
|
---|
| 47 | <status_value>completed</status_value>
|
---|
| 48 | <test_value>BUN</test_value>
|
---|
| 49 | <type_value>CH</type_value>
|
---|
| 50 | <units_value>mg/dL</units_value>
|
---|
| 51 | <vuid_value>4656523</vuid_value>
|
---|
| 52 | </rdf:Description>
|
---|
| 53 | <rdf:Description rdf:about="/dewdrop/patient/32/lab/2">
|
---|
| 54 | <collected_value>3110626.16</collected_value>
|
---|
| 55 | <space xmlns="comment@xml">preserve</space>
|
---|
| 56 | <comment>Report Released Date/Time: Jun 26, 2011@19:00</comment>
|
---|
| 57 | <facility_code>100</facility_code>
|
---|
| 58 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 59 | <groupName_value>CH 0626 47</groupName_value>
|
---|
| 60 | <high_value> 1.4</high_value>
|
---|
| 61 | <id_value>CH;6889372.84;4</id_value>
|
---|
| 62 | <labOrderID_value>336</labOrderID_value>
|
---|
| 63 | <localName_value>CREAT</localName_value>
|
---|
| 64 | <loinc_value>14682-9</loinc_value>
|
---|
| 65 | <low_value>.9 </low_value>
|
---|
| 66 | <orderID_value>808</orderID_value>
|
---|
| 67 | <rdf:type rdf:resource="lab"/>
|
---|
| 68 | <result_value>1.0</result_value>
|
---|
| 69 | <resulted_value>3110626.190006</resulted_value>
|
---|
| 70 | <sample_value>SERUM</sample_value>
|
---|
| 71 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 72 | <specimen_code>0X500</specimen_code>
|
---|
| 73 | <specimen_name>SERUM</specimen_name>
|
---|
| 74 | <status_value>completed</status_value>
|
---|
| 75 | <test_value>CREATININE</test_value>
|
---|
| 76 | <type_value>CH</type_value>
|
---|
| 77 | <units_value>mg/dL</units_value>
|
---|
| 78 | <vuid_value>4656243</vuid_value>
|
---|
| 79 | </rdf:Description>
|
---|
| 80 | <rdf:Description rdf:about="/dewdrop/patient/32/lab/3">
|
---|
| 81 | <collected_value>3110626.16</collected_value>
|
---|
| 82 | <space xmlns="comment@xml">preserve</space>
|
---|
| 83 | <comment>Report Released Date/Time: Jun 26, 2011@19:00</comment>
|
---|
| 84 | <facility_code>100</facility_code>
|
---|
| 85 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 86 | <groupName_value>CH 0626 47</groupName_value>
|
---|
| 87 | <high_value> 145</high_value>
|
---|
| 88 | <id_value>CH;6889372.84;5</id_value>
|
---|
| 89 | <labOrderID_value>336</labOrderID_value>
|
---|
| 90 | <localName_value>NA</localName_value>
|
---|
| 91 | <loinc_value>2951-2</loinc_value>
|
---|
| 92 | <low_value>135 </low_value>
|
---|
| 93 | <orderID_value>810</orderID_value>
|
---|
| 94 | <rdf:type rdf:resource="lab"/>
|
---|
| 95 | <result_value>141</result_value>
|
---|
| 96 | <resulted_value>3110626.190006</resulted_value>
|
---|
| 97 | <sample_value>SERUM</sample_value>
|
---|
| 98 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 99 | <specimen_code>0X500</specimen_code>
|
---|
| 100 | <specimen_name>SERUM</specimen_name>
|
---|
| 101 | <status_value>completed</status_value>
|
---|
| 102 | <test_value>SODIUM</test_value>
|
---|
| 103 | <type_value>CH</type_value>
|
---|
| 104 | <units_value>meq/L</units_value>
|
---|
| 105 | <vuid_value>4671912</vuid_value>
|
---|
| 106 | </rdf:Description>
|
---|
| 107 | <rdf:Description rdf:about="/dewdrop/patient/32/lab/4">
|
---|
| 108 | <collected_value>3110626.16</collected_value>
|
---|
| 109 | <space xmlns="comment@xml">preserve</space>
|
---|
| 110 | <comment>Report Released Date/Time: Jun 26, 2011@19:00</comment>
|
---|
| 111 | <facility_code>100</facility_code>
|
---|
| 112 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 113 | <groupName_value>CH 0626 47</groupName_value>
|
---|
| 114 | <high_value> 200</high_value>
|
---|
| 115 | <id_value>CH;6889372.84;12</id_value>
|
---|
| 116 | <labOrderID_value>336</labOrderID_value>
|
---|
| 117 | <localName_value>CHOL</localName_value>
|
---|
| 118 | <loinc_value>14647-2</loinc_value>
|
---|
| 119 | <low_value>120 </low_value>
|
---|
| 120 | <orderID_value>806</orderID_value>
|
---|
| 121 | <rdf:type rdf:resource="lab"/>
|
---|
| 122 | <result_value>162</result_value>
|
---|
| 123 | <resulted_value>3110626.190006</resulted_value>
|
---|
| 124 | <sample_value>SERUM</sample_value>
|
---|
| 125 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 126 | <specimen_code>0X500</specimen_code>
|
---|
| 127 | <specimen_name>SERUM</specimen_name>
|
---|
| 128 | <status_value>completed</status_value>
|
---|
| 129 | <test_value>CHOLESTEROL</test_value>
|
---|
| 130 | <type_value>CH</type_value>
|
---|
| 131 | <units_value>mg/dL</units_value>
|
---|
| 132 | <vuid_value>4656205</vuid_value>
|
---|
| 133 | </rdf:Description>
|
---|
| 134 | <rdf:Description rdf:about="/dewdrop/patient/32/lab/5">
|
---|
| 135 | <collected_value>3110626.16</collected_value>
|
---|
| 136 | <space xmlns="comment@xml">preserve</space>
|
---|
| 137 | <comment>Report Released Date/Time: Jun 26, 2011@19:00</comment>
|
---|
| 138 | <facility_code>100</facility_code>
|
---|
| 139 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 140 | <groupName_value>CH 0626 47</groupName_value>
|
---|
| 141 | <high_value> 150</high_value>
|
---|
| 142 | <id_value>CH;6889372.84;47</id_value>
|
---|
| 143 | <interpretation_value>H</interpretation_value>
|
---|
| 144 | <labOrderID_value>336</labOrderID_value>
|
---|
| 145 | <localName_value>TRIGLYC</localName_value>
|
---|
| 146 | <loinc_value>14927-8</loinc_value>
|
---|
| 147 | <low_value>36 </low_value>
|
---|
| 148 | <orderID_value>805</orderID_value>
|
---|
| 149 | <rdf:type rdf:resource="lab"/>
|
---|
| 150 | <result_value>177</result_value>
|
---|
| 151 | <resulted_value>3110626.190006</resulted_value>
|
---|
| 152 | <sample_value>SERUM</sample_value>
|
---|
| 153 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 154 | <specimen_code>0X500</specimen_code>
|
---|
| 155 | <specimen_name>SERUM</specimen_name>
|
---|
| 156 | <status_value>completed</status_value>
|
---|
| 157 | <test_value>TRIGLYCERIDE</test_value>
|
---|
| 158 | <type_value>CH</type_value>
|
---|
| 159 | <units_value>mg/dL</units_value>
|
---|
| 160 | <vuid_value>4656512</vuid_value>
|
---|
| 161 | </rdf:Description>
|
---|
| 162 | <rdf:Description rdf:about="/dewdrop/patient/32/lab/6">
|
---|
| 163 | <collected_value>3110626.16</collected_value>
|
---|
| 164 | <space xmlns="comment@xml">preserve</space>
|
---|
| 165 | <comment>Report Released Date/Time: Jun 26, 2011@19:00</comment>
|
---|
| 166 | <facility_code>100</facility_code>
|
---|
| 167 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 168 | <groupName_value>CH 0626 47</groupName_value>
|
---|
| 169 | <id_value>CH;6889372.84;80</id_value>
|
---|
| 170 | <labOrderID_value>336</labOrderID_value>
|
---|
| 171 | <localName_value>HDL</localName_value>
|
---|
| 172 | <loinc_value>14646-4</loinc_value>
|
---|
| 173 | <orderID_value>804</orderID_value>
|
---|
| 174 | <rdf:type rdf:resource="lab"/>
|
---|
| 175 | <result_value>43</result_value>
|
---|
| 176 | <resulted_value>3110626.190006</resulted_value>
|
---|
| 177 | <sample_value>SERUM</sample_value>
|
---|
| 178 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 179 | <specimen_code>0X500</specimen_code>
|
---|
| 180 | <specimen_name>SERUM</specimen_name>
|
---|
| 181 | <status_value>completed</status_value>
|
---|
| 182 | <test_value>HDL</test_value>
|
---|
| 183 | <type_value>CH</type_value>
|
---|
| 184 | <units_value>MG/DL</units_value>
|
---|
| 185 | <vuid_value>4656204</vuid_value>
|
---|
| 186 | </rdf:Description>
|
---|
| 187 | <rdf:Description rdf:about="/dewdrop/patient/32/lab/7">
|
---|
| 188 | <collected_value>3110626.16</collected_value>
|
---|
| 189 | <space xmlns="comment@xml">preserve</space>
|
---|
| 190 | <comment>Report Released Date/Time: Jun 26, 2011@19:00</comment>
|
---|
| 191 | <facility_code>100</facility_code>
|
---|
| 192 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 193 | <groupName_value>CH 0626 47</groupName_value>
|
---|
| 194 | <id_value>CH;6889372.84;291</id_value>
|
---|
| 195 | <labOrderID_value>336</labOrderID_value>
|
---|
| 196 | <localName_value>LDL CHO</localName_value>
|
---|
| 197 | <loinc_value>2089-1</loinc_value>
|
---|
| 198 | <orderID_value>803</orderID_value>
|
---|
| 199 | <rdf:type rdf:resource="lab"/>
|
---|
| 200 | <result_value>84</result_value>
|
---|
| 201 | <resulted_value>3110626.190006</resulted_value>
|
---|
| 202 | <sample_value>SERUM</sample_value>
|
---|
| 203 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 204 | <specimen_code>0X500</specimen_code>
|
---|
| 205 | <specimen_name>SERUM</specimen_name>
|
---|
| 206 | <status_value>completed</status_value>
|
---|
| 207 | <test_value>LDL CHOLESTEROL</test_value>
|
---|
| 208 | <type_value>CH</type_value>
|
---|
| 209 | <units_value>MG/DL</units_value>
|
---|
| 210 | <vuid_value>4662734</vuid_value>
|
---|
| 211 | </rdf:Description>
|
---|
| 212 | <rdf:Description rdf:about="/dewdrop/patient/32/lab/8">
|
---|
| 213 | <collected_value>3110626.16</collected_value>
|
---|
| 214 | <space xmlns="comment@xml">preserve</space>
|
---|
| 215 | <comment>Report Released Date/Time: Jun 26, 2011@19:00</comment>
|
---|
| 216 | <facility_code>100</facility_code>
|
---|
| 217 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 218 | <groupName_value>CH 0626 47</groupName_value>
|
---|
| 219 | <high_value> 101</high_value>
|
---|
| 220 | <id_value>CH;6889372.84;67003</id_value>
|
---|
| 221 | <interpretation_value>H</interpretation_value>
|
---|
| 222 | <labOrderID_value>336</labOrderID_value>
|
---|
| 223 | <localName_value>FBLDGLU</localName_value>
|
---|
| 224 | <loinc_value>14771-0</loinc_value>
|
---|
| 225 | <low_value>69 </low_value>
|
---|
| 226 | <orderID_value>807</orderID_value>
|
---|
| 227 | <rdf:type rdf:resource="lab"/>
|
---|
| 228 | <result_value>178</result_value>
|
---|
| 229 | <resulted_value>3110626.190006</resulted_value>
|
---|
| 230 | <sample_value>SERUM</sample_value>
|
---|
| 231 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 232 | <specimen_code>0X500</specimen_code>
|
---|
| 233 | <specimen_name>SERUM</specimen_name>
|
---|
| 234 | <status_value>completed</status_value>
|
---|
| 235 | <test_value>FASTING BLOOD GLUCOSE</test_value>
|
---|
| 236 | <type_value>CH</type_value>
|
---|
| 237 | <units_value>MG/DL</units_value>
|
---|
| 238 | <vuid_value>4656342</vuid_value>
|
---|
| 239 | </rdf:Description>
|
---|
| 240 | <rdf:Description rdf:about="/dewdrop/patient/32/med/1">
|
---|
| 241 | <doses-dose_dose>0</doses-dose_dose>
|
---|
| 242 | <doses-dose_route>by mouth</doses-dose_route>
|
---|
| 243 | <doses-dose_schedule>DAILY</doses-dose_schedule>
|
---|
| 244 | <facility_code>050</facility_code>
|
---|
| 245 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 246 | <form_value>TAB</form_value>
|
---|
| 247 | <id_value>1N;O</id_value>
|
---|
| 248 | <name_value>GLYBURIDE TAB</name_value>
|
---|
| 249 | <ordered_value>3110624.191511</ordered_value>
|
---|
| 250 | <orderingProvider_code>63</orderingProvider_code>
|
---|
| 251 | <orderingProvider_name>KING,MATTHEW MICHAEL</orderingProvider_name>
|
---|
| 252 | <products-product-class_code>ORAL HYPOGLYCEMIC AGENTS,ORAL</products-product-class_code>
|
---|
| 253 | <products-product-vaGeneric_code>400</products-product-vaGeneric_code>
|
---|
| 254 | <products-product-vaGeneric_name>GLYBURIDE</products-product-vaGeneric_name>
|
---|
| 255 | <products-product-vaGeneric_vuid>4018078</products-product-vaGeneric_vuid>
|
---|
| 256 | <products-product-vaProduct_code>2877</products-product-vaProduct_code>
|
---|
| 257 | <products-product-vaProduct_name>GLYBURIDE 2.5MG TAB</products-product-vaProduct_name>
|
---|
| 258 | <products-product-vaProduct_vuid>4003456</products-product-vaProduct_vuid>
|
---|
| 259 | <products-product_code>235</products-product_code>
|
---|
| 260 | <products-product_name>GLYBURIDE 2.5MG U/D</products-product_name>
|
---|
| 261 | <products-product_role>D</products-product_role>
|
---|
| 262 | <rdf:type rdf:resource="med"/>
|
---|
| 263 | <space xmlns="sig@xml">preserve</space>
|
---|
| 264 | <sig>Glyburide 2.5 mg Tab| 1 tablet BY by mouth DAILY</sig>
|
---|
| 265 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 266 | <start_value>3110624.1818</start_value>
|
---|
| 267 | <status_value>active</status_value>
|
---|
| 268 | <type_value>OTC</type_value>
|
---|
| 269 | <vaType_value>N</vaType_value>
|
---|
| 270 | </rdf:Description>
|
---|
| 271 | <rdf:Description rdf:about="/dewdrop/patient/32/med/2">
|
---|
| 272 | <doses-dose_dose>0</doses-dose_dose>
|
---|
| 273 | <doses-dose_route>by mouth</doses-dose_route>
|
---|
| 274 | <doses-dose_schedule>BID</doses-dose_schedule>
|
---|
| 275 | <doses-dose_units> mg Tab| 1 tablet</doses-dose_units>
|
---|
| 276 | <facility_code>050</facility_code>
|
---|
| 277 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 278 | <form_value>TAB</form_value>
|
---|
| 279 | <id_value>2N;O</id_value>
|
---|
| 280 | <name_value>FUROSEMIDE TAB</name_value>
|
---|
| 281 | <ordered_value>3110624.191511</ordered_value>
|
---|
| 282 | <orderingProvider_code>63</orderingProvider_code>
|
---|
| 283 | <orderingProvider_name>KING,MATTHEW MICHAEL</orderingProvider_name>
|
---|
| 284 | <products-product-class_code>LOOP DIURETICS</products-product-class_code>
|
---|
| 285 | <products-product-vaGeneric_code>197</products-product-vaGeneric_code>
|
---|
| 286 | <products-product-vaGeneric_name>FUROSEMIDE</products-product-vaGeneric_name>
|
---|
| 287 | <products-product-vaGeneric_vuid>4017830</products-product-vaGeneric_vuid>
|
---|
| 288 | <products-product-vaProduct_code>1784</products-product-vaProduct_code>
|
---|
| 289 | <products-product-vaProduct_name>FUROSEMIDE 20MG TAB</products-product-vaProduct_name>
|
---|
| 290 | <products-product-vaProduct_vuid>4002369</products-product-vaProduct_vuid>
|
---|
| 291 | <products-product_code>228</products-product_code>
|
---|
| 292 | <products-product_name>FUROSEMIDE 20MG U/D</products-product_name>
|
---|
| 293 | <products-product_role>D</products-product_role>
|
---|
| 294 | <rdf:type rdf:resource="med"/>
|
---|
| 295 | <space xmlns="sig@xml">preserve</space>
|
---|
| 296 | <sig>Lasix 20 mg Tab| 1 tablet BY by mouth BID</sig>
|
---|
| 297 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 298 | <start_value>3110624.182</start_value>
|
---|
| 299 | <status_value>active</status_value>
|
---|
| 300 | <type_value>OTC</type_value>
|
---|
| 301 | <vaType_value>N</vaType_value>
|
---|
| 302 | </rdf:Description>
|
---|
| 303 | <rdf:Description rdf:about="/dewdrop/patient/32/med/3">
|
---|
| 304 | <doses-dose_dose>0</doses-dose_dose>
|
---|
| 305 | <doses-dose_route>by mouth</doses-dose_route>
|
---|
| 306 | <doses-dose_schedule>DAILY</doses-dose_schedule>
|
---|
| 307 | <doses-dose_units> mg Tab| 1 tablet</doses-dose_units>
|
---|
| 308 | <facility_code>050</facility_code>
|
---|
| 309 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 310 | <form_value>TAB</form_value>
|
---|
| 311 | <id_value>3N;O</id_value>
|
---|
| 312 | <name_value>ATORVASTATIN TAB</name_value>
|
---|
| 313 | <ordered_value>3110624.191511</ordered_value>
|
---|
| 314 | <orderingProvider_code>63</orderingProvider_code>
|
---|
| 315 | <orderingProvider_name>KING,MATTHEW MICHAEL</orderingProvider_name>
|
---|
| 316 | <products-product-class_code>ANTILIPEMIC AGENTS</products-product-class_code>
|
---|
| 317 | <products-product-vaGeneric_code>3382</products-product-vaGeneric_code>
|
---|
| 318 | <products-product-vaGeneric_name>ATORVASTATIN</products-product-vaGeneric_name>
|
---|
| 319 | <products-product-vaGeneric_vuid>4024041</products-product-vaGeneric_vuid>
|
---|
| 320 | <products-product-vaProduct_code>12595</products-product-vaProduct_code>
|
---|
| 321 | <products-product-vaProduct_name>ATORVASTATIN CA 10MG TAB</products-product-vaProduct_name>
|
---|
| 322 | <products-product-vaProduct_vuid>4012960</products-product-vaProduct_vuid>
|
---|
| 323 | <products-product_code>94208</products-product_code>
|
---|
| 324 | <products-product_name>ATORVASTATIN 10MG</products-product_name>
|
---|
| 325 | <products-product_role>D</products-product_role>
|
---|
| 326 | <rdf:type rdf:resource="med"/>
|
---|
| 327 | <space xmlns="sig@xml">preserve</space>
|
---|
| 328 | <sig>Lipitor 10 mg Tab| 1 tablet BY by mouth DAILY</sig>
|
---|
| 329 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 330 | <start_value>3110624.1819</start_value>
|
---|
| 331 | <status_value>active</status_value>
|
---|
| 332 | <type_value>OTC</type_value>
|
---|
| 333 | <vaType_value>N</vaType_value>
|
---|
| 334 | </rdf:Description>
|
---|
| 335 | <rdf:Description rdf:about="/dewdrop/patient/32/med/4">
|
---|
| 336 | <doses-dose_dose>0</doses-dose_dose>
|
---|
| 337 | <doses-dose_route>by mouth</doses-dose_route>
|
---|
| 338 | <doses-dose_schedule>BID</doses-dose_schedule>
|
---|
| 339 | <doses-dose_units> 1</doses-dose_units>
|
---|
| 340 | <facility_code>050</facility_code>
|
---|
| 341 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 342 | <form_value>TAB,SA</form_value>
|
---|
| 343 | <id_value>4N;O</id_value>
|
---|
| 344 | <name_value>POTASSIUM CHLORIDE TAB,SA</name_value>
|
---|
| 345 | <ordered_value>3110624.191511</ordered_value>
|
---|
| 346 | <orderingProvider_code>63</orderingProvider_code>
|
---|
| 347 | <orderingProvider_name>KING,MATTHEW MICHAEL</orderingProvider_name>
|
---|
| 348 | <products-product-class_code>POTASSIUM</products-product-class_code>
|
---|
| 349 | <products-product-vaGeneric_code>19</products-product-vaGeneric_code>
|
---|
| 350 | <products-product-vaGeneric_name>POTASSIUM CHLORIDE</products-product-vaGeneric_name>
|
---|
| 351 | <products-product-vaGeneric_vuid>4017447</products-product-vaGeneric_vuid>
|
---|
| 352 | <products-product-vaProduct_code>234</products-product-vaProduct_code>
|
---|
| 353 | <products-product-vaProduct_name>POTASSIUM CHLORIDE 10MEQ TAB,SA</products-product-vaProduct_name>
|
---|
| 354 | <products-product-vaProduct_vuid>4000856</products-product-vaProduct_vuid>
|
---|
| 355 | <products-product_code>5233</products-product_code>
|
---|
| 356 | <products-product_name>POTASSIUM CHLORIDE 10MEQ TAB</products-product_name>
|
---|
| 357 | <products-product_role>D</products-product_role>
|
---|
| 358 | <rdf:type rdf:resource="med"/>
|
---|
| 359 | <space xmlns="sig@xml">preserve</space>
|
---|
| 360 | <sig>Klor-Con 10 10 mEq Tab| 1 tablet BY by mouth BID</sig>
|
---|
| 361 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 362 | <start_value>3110624.1822</start_value>
|
---|
| 363 | <status_value>active</status_value>
|
---|
| 364 | <type_value>OTC</type_value>
|
---|
| 365 | <vaType_value>N</vaType_value>
|
---|
| 366 | </rdf:Description>
|
---|
| 367 | <rdf:Description rdf:about="/dewdrop/patient/32/patient/1">
|
---|
| 368 | <address_city>TULSA</address_city>
|
---|
| 369 | <address_postalCode>74108</address_postalCode>
|
---|
| 370 | <address_stateProvince>OKLAHOMA</address_stateProvince>
|
---|
| 371 | <address_streetLine1>12 E.36th St</address_streetLine1>
|
---|
| 372 | <bid_value>H2653P</bid_value>
|
---|
| 373 | <dob_value>2530126</dob_value>
|
---|
| 374 | <exposures-exposure_value>AO</exposures-exposure_value>
|
---|
| 375 | <facilities-facility_code>050</facilities-facility_code>
|
---|
| 376 | <facilities-facility_name>VOE OFFICE INSTITUTION</facilities-facility_name>
|
---|
| 377 | <familyName_value>HARRIS</familyName_value>
|
---|
| 378 | <fullName_value>HARRIS,JOHN</fullName_value>
|
---|
| 379 | <gender_value>M</gender_value>
|
---|
| 380 | <givenNames_value>JOHN</givenNames_value>
|
---|
| 381 | <id_value>32</id_value>
|
---|
| 382 | <lrdfn_value>36</lrdfn_value>
|
---|
| 383 | <rdf:type rdf:resource="patient"/>
|
---|
| 384 | <sc_value>0</sc_value>
|
---|
| 385 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 386 | <ssn_value>403012653P</ssn_value>
|
---|
| 387 | <veteran_value>0</veteran_value>
|
---|
| 388 | </rdf:Description>
|
---|
| 389 | <rdf:Description rdf:about="/dewdrop/patient/32/problem/1">
|
---|
| 390 | <acuity_value>C</acuity_value>
|
---|
| 391 | <entered_value>3110505</entered_value>
|
---|
| 392 | <facility_code>100</facility_code>
|
---|
| 393 | <facility_name>VOE OFFICE INSTITUTION OLD</facility_name>
|
---|
| 394 | <icd_value>250.02</icd_value>
|
---|
| 395 | <id_value>57</id_value>
|
---|
| 396 | <name_value>Diabetes Mellitus without mention of Complication, type II or unspecified type,</name_value>
|
---|
| 397 | <onset_value>3030405</onset_value>
|
---|
| 398 | <provider_code>76</provider_code>
|
---|
| 399 | <provider_name>VAN NESS,NANCY</provider_name>
|
---|
| 400 | <rdf:type rdf:resource="problem"/>
|
---|
| 401 | <removed_value>0</removed_value>
|
---|
| 402 | <sc_value>0</sc_value>
|
---|
| 403 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 404 | <status_value>A</status_value>
|
---|
| 405 | <unverified_value>0</unverified_value>
|
---|
| 406 | <updated_value>3110624</updated_value>
|
---|
| 407 | </rdf:Description>
|
---|
| 408 | <rdf:Description rdf:about="/dewdrop/patient/32/problem/2">
|
---|
| 409 | <acuity_value>C</acuity_value>
|
---|
| 410 | <entered_value>3110505</entered_value>
|
---|
| 411 | <facility_code>100</facility_code>
|
---|
| 412 | <facility_name>VOE OFFICE INSTITUTION OLD</facility_name>
|
---|
| 413 | <icd_value>401.9</icd_value>
|
---|
| 414 | <id_value>58</id_value>
|
---|
| 415 | <name_value>Essential Hypertension</name_value>
|
---|
| 416 | <onset_value>3070506</onset_value>
|
---|
| 417 | <provider_code>76</provider_code>
|
---|
| 418 | <provider_name>VAN NESS,NANCY</provider_name>
|
---|
| 419 | <rdf:type rdf:resource="problem"/>
|
---|
| 420 | <removed_value>0</removed_value>
|
---|
| 421 | <sc_value>0</sc_value>
|
---|
| 422 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 423 | <status_value>A</status_value>
|
---|
| 424 | <unverified_value>0</unverified_value>
|
---|
| 425 | <updated_value>3110624</updated_value>
|
---|
| 426 | </rdf:Description>
|
---|
| 427 | <rdf:Description rdf:about="/dewdrop/patient/32/problem/3">
|
---|
| 428 | <acuity_value>C</acuity_value>
|
---|
| 429 | <entered_value>3110624</entered_value>
|
---|
| 430 | <facility_code>100</facility_code>
|
---|
| 431 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 432 | <icd_value>414.01</icd_value>
|
---|
| 433 | <id_value>172</id_value>
|
---|
| 434 | <location_value>DR OFFICE</location_value>
|
---|
| 435 | <name_value>Coronary Atherosclerosis of Native Coronary Vessel</name_value>
|
---|
| 436 | <onset_value>3020504</onset_value>
|
---|
| 437 | <provider_code>63</provider_code>
|
---|
| 438 | <provider_name>KING,MATTHEW MICHAEL</provider_name>
|
---|
| 439 | <rdf:type rdf:resource="problem"/>
|
---|
| 440 | <removed_value>0</removed_value>
|
---|
| 441 | <sc_value>0</sc_value>
|
---|
| 442 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 443 | <status_value>A</status_value>
|
---|
| 444 | <unverified_value>0</unverified_value>
|
---|
| 445 | <updated_value>3110624</updated_value>
|
---|
| 446 | </rdf:Description>
|
---|
| 447 | <rdf:Description rdf:about="/dewdrop/patient/32/problem/4">
|
---|
| 448 | <acuity_value>C</acuity_value>
|
---|
| 449 | <entered_value>3110624</entered_value>
|
---|
| 450 | <facility_code>100</facility_code>
|
---|
| 451 | <facility_name>VOE OFFICE INSTITUTION</facility_name>
|
---|
| 452 | <icd_value>272.4</icd_value>
|
---|
| 453 | <id_value>173</id_value>
|
---|
| 454 | <location_value>DR OFFICE</location_value>
|
---|
| 455 | <name_value>Other and unspecified hyperlipidemia</name_value>
|
---|
| 456 | <onset_value>3050405</onset_value>
|
---|
| 457 | <provider_code>63</provider_code>
|
---|
| 458 | <provider_name>KING,MATTHEW MICHAEL</provider_name>
|
---|
| 459 | <rdf:type rdf:resource="problem"/>
|
---|
| 460 | <removed_value>0</removed_value>
|
---|
| 461 | <sc_value>0</sc_value>
|
---|
| 462 | <belongsTo xmlns="http://smartplatforms.org/terms#" rdf:resource="/dewdrop/patient/32"/>
|
---|
| 463 | <status_value>A</status_value>
|
---|
| 464 | <unverified_value>0</unverified_value>
|
---|
| 465 | <updated_value>3110624</updated_value>
|
---|
| 466 | </rdf:Description>
|
---|
| 467 | </rdf:RDF>
|
---|